Evidence map›Paper›PMID 25381334›Full record

ArticleHuman molecular genetics2015

Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation.

Allison M Cotton, E Magda Price, Meaghan J Jones, Bradley P Balaton, Michael S Kobor, Carolyn J Brown

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 2 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 2 syntheses or guidelines pooled it, 274 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Allison M CottonDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3.
E Magda PriceDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC, Canada V5Z 4H4, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4.
Meaghan J JonesDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4 Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada V5Z 4H4.
Bradley P BalatonDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3.
Michael S KoborDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, The Child and Family Research Institute, Vancouver, BC, Canada V5Z 4H4 Centre for Molecular Medicine and Therapeutics, Vancouver, BC, Canada V5Z 4H4.
Carolyn J BrownDepartment of Medical Genetics, University of British Columbia, Vancouver, BC, Canada V6T 1Z3, Molecular Epigenetics Group, Life Sciences Institute, Vancouver, BC, Canada V6T 1Z3, carolyn.brown@ubc.ca.
University of British Columbia · CAChild and Family Research Institute · CA

Funding

Canadian Institutes of Health Research MOP-13690
6 · The paper itself

Abstract

X-chromosome inactivation (XCI) achieves dosage compensation between males and females through the silencing of the majority of genes on one of the female X chromosomes. Thus, the female X chromosomes provide a unique opportunity to study euchromatin and heterochromatin of allelic regions within the same nuclear environment. We examined the interplay of DNA methylation (DNAm) with CpG density, transcriptional activity and chromatin state at genes on the X chromosome using over 1800 female samples analysed with the Illumina Infinium Human Methylation450 BeadChip. DNAm was used to predict an inactivation status for 63 novel transcription start sites (TSSs) across 27 tissues. There was high concordance of inactivation status across tissues, with 62% of TSSs subject to XCI in all 27 tissues examined, whereas 9% escaped from XCI in all tissues, and the remainder showed variable escape from XCI between females in subsets of tissues. Inter-female and twin data supported a model of predominately cis-acting influences on inactivation status. The level of expression from the inactive X relative to the active X correlated with the amount of female promoter DNAm to a threshold of ∼30%, beyond which genes were consistently subject to inactivation. The inactive X showed lower DNAm than the active X at intragenic and intergenic regions for genes subject to XCI, but not at genes that escape from inactivation. Our categorization of genes that escape from X inactivation provides candidates for sex-specific differences in disease.

Indexed as

Chromosomes, Human, XCpG IslandsDNA MethylationX Chromosome InactivationChromatinDNA, IntergenicFemaleGene Expression RegulationHumansOligonucleotide Array Sequence AnalysisOrgan SpecificityPromoter Regions, GeneticTranscription, GeneticChromatinDNA, Intergenic

Identifiers

PMID25381334
PMCPMC4381753
OpenAlexW2165556149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.